International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Stalicla SA
Study ID
NCT05590715
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 65 Years
Healthy Volunteers
Not accepted

Study Details

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Key Dates

Start date
Oct 13, 2022
Status verified
Feb 2026
Primary completion
Mar 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

Clinical characterisation of the ASD-Phen1 and ASD-Phen2 subpopulations. [ Time Frame: Day 0 ]

Central Contacts

Locations (9)

FacilityCityStateZIPSite coordinators
SARRCPhoenixArizona85006
Riley Stark
[email protected]
480-351-0567
California Neuroscience ResearchSherman OaksCalifornia91403
Jessica Vuong
[email protected]
818-990-2671
BioPhase ResearchMiamiFlorida33137-
The Angel Medical ResearchMiami LakesFlorida33016-
Rush University Medical CenterChicagoIllinois60612
Melissa Baer
Caceres Tamar, MD (PRINCIPAL_INVESTIGATOR)
University of Missouri, Thompson Center for Autism & Neurodevelopmental DisordersColumbiaMissouri65211
Nicole Takahashi
David Berversdorf, MD (PRINCIPAL_INVESTIGATOR)
Golden Hearts DiagnosticAlamogordoNew Mexico88210-
Red Oak Psychiatry AssociatesHoustonTexas77090-
Alpine Research OrganizationClintonUtah84015
Amy Kenley

Find similar trials in Phoenix, AZ

By condition
Autism spectrum disorder
By specialty
Pediatrics
By research site
SARRC· Phoenix, AZCalifornia Neuroscience Research· Sherman Oaks, CABioPhase Research· Miami, FLThe Angel Medical Research· Miami Lakes, FLRush University Medical Center· Chicago, ILUniversity of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders· Columbia, MO

Related Studies